Visalytics
Visalytics
approved EB-2 (NIW)

Staff Scientist

Proteomics Of Pathogenesis · India · 2025-01-28

Processing Time
80 days
Decision Date
2025-01-28
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop mass spectrometry-based proteomic approaches to analyze virus surface glycoproteins to advance vaccine development against viral diseases. This work focuses on identifying and characterizing glycoproteins to gain insights into viral structure, infection mechanisms, and immune evasion strategies. The intended impact is to streamline the creation of vaccines that effectively target viral entry points and neutralize infections.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research on viral glycoproteins is essential for advancing vaccines and curbing the spread of infectious diseases in vulnerable populations.

2 Well-positioned to Advance the Endeavor Met

The petitioner's education, expertise, and extensive publication and citation record indicate they are well-positioned to succeed.

3 Balance of Interests Met

The petitioner's contributions to biomedical technologies make them an invaluable asset, justifying the waiver of the job offer requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in pathology and a significant record of 1,179 citations. Evidence included 17 peer-reviewed journal articles, 8 abstracts, 2 preprints, and 1 book chapter, along with 18 completed peer reviews. The case successfully satisfied all three Dhanasar prongs, supported by four expert recommendation letters and funding from the NIH and the Bill and Melinda Gates Foundation.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Reference Letters Independent
Grants
Conference Presentations
Original Contributions
Government Alignment

Similar Cases

Research Scientist

Biotechnology

WeGreened EB-2 (NIW) approved
8 days 2025-07-05
The petitioner proposes to develop advanced mass spectrometry-based proteomics workflows to facilitate precision oncology and biomarker discovery. This research aims to enhance the accuracy of cancer diagnosis and improve targeted therapies by addressing the molecular heterogeneity of cancer.
View Case

Biochemist

Biotechnology · Sri Lanka

WeGreened EB-2 (NIW) approved
New Jersey 4 days 2025-04-22
The petitioner proposes to continue his research in biochemistry, specifically focusing on developing innovative protocols and tools for the purification and analysis of plasmid DNA and proteins. This work aims to eliminate technical obstacles in the biopharmaceutical sector to accelerate the development of vaccines and antibodies. The endeavor is designed to enhance biomarker development and ensure the quality and stability of plasma and serum samples used in cancer research.
View Case

Postdoctoral Researcher

Biotechnology

WeGreened EB-2 (NIW) approved
Texas 26 days 2025-02-05
The petitioner proposes to continue investigating the molecular dynamics of viral replication and pathogenesis using model viral systems at a U.S. academic institution. This work focuses on exploring viral-host interactions and immune evasion strategies to facilitate the development of advanced vaccine platforms and targeted antiviral therapies. The endeavor aims to strengthen the United States' defense against viral epidemics and bioterrorism threats.
View Case

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
Pennsylvania 64 days 2025-11-26
The petitioner proposes to continue research on the fundamental mechanisms of cellular stress response and immune system function to advance vaccine development and biotherapeutics. The work utilizes antibody engineering and advanced sequencing technologies to create practical innovations for protecting vulnerable populations from respiratory infections. The intended impact is to address nationwide public health challenges and improve national health security through immediate therapeutic potential.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-28.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 80 days
Criteria Met 3 / 3
Evidence Types 8

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,814
Success Rate 53.6%
Sustained 2,046
Dismissed 1,672

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist